Group 1B: Metastatic Breast Cancer; Pharmacokinetics; Drug Dosing; Triple-Negative Breast Cancer

Poster #P1-09-25: Population Pharmacokinetics (PopPK) and Exposure- Response (E-R) Analyses of Sacituzumab Govitecan (SG) in Japanese Patients (pts) with Metastatic Triple-Negative Breast Cancer (mTNBC) and other Advanced Solid Tumors

Poster #P3-10-18: Phase II Single Arm Trial of Low Dose Capecitabine in Patients with Advanced Breast Cancer (NCT06105684)